Global Blue Biotechnology Market By Product (Oil, Functional Ingredient and animal feed, Pharmaceuticals and Nutraceuticals, Foods and food additives, Cosmetics, Materials (e.g. clothes and construction materials), Energy, Others); By Usage (Human, Pets, Aquaculture); By Application (Bio-Engineering, Drug Discovery, Genomics, Vaccines, Others); By End Users (Hospitals, Research and Academic Institutes, Biotechnology and Pharmaceutical Institutes, Laboratories, Others); By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2023 – 2031
Industry Trends
Blue biotechnology happens to be a field of biotechnology that is concentrates on the exploration and exploitation of the diverse range of marine resources for various applications in different fields. It involves the study of marine organisms, their genetic composition, and their biochemical and physiological properties for the development of products and applications in fields such as pharmaceuticals, agriculture, food, and energy. The marine environment is a rich source of bioactive compounds that possess potential applications in various industries. Similar to marine organisms like bacteria, fungi, algae, and sponges produce unique bioactive compounds that have been found to have antibiotic, antitumor, anti-inflammatory, and antiviral properties. Blue biotechnology has the potential to contribute to the sustainable development of marine resources and to the development of new products and technologies that can benefit society. However, it is important to ensure that the exploitation of these resources is done in a responsible and sustainable way, to minimize the impact on marine ecosystems and to ensure their long-term viability.
Blue biotechnology can be used in various things like development of new medicines, enhancing farming along with developing new renewable sources of energy. As marine organisms have been found to produce bioactive compounds that can be used to develop new medicines. Meanwhile, this biotechnology has the potential to develop new methods of sustainable aquaculture and fish farming and this is capable of helping meet the growing demand for seafood while reducing the pressure on wild fish populations. On the other hand, the blue biotechnology can also be used to develop new renewable energy sources. For instance, microalgae can be used to produce biofuels, while ocean currents and tides can be harnessed to generate electricity. And this is the reason why the global blue biotechnology market is growing rampantly.
In terms of revenue, the global blue biotechnology market is projected to reach US$ 5.9 Bn by 2031, growing at a CAGR of 7.8% over the forecast period (2023 – 2031). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Product Outlook
Based on the product outlook, the global blue biotechnology market has been segregated into oil, functional ingredient and animal feed, pharmaceuticals and nutraceuticals, food and food additives, cosmetics, materials (e.g. clothes and construction materials), energy and others. The pharmaceuticals and nutraceuticals segment makes majority of the money for the market owing to use of rare organisms found in the seas and oceans.
Region Outlook
On the basis of the region, the continent of North America has been minting most of the money for the global blue biotechnology market in the year 2022. Higher investments into medical research and technological advancement in the region drives the growth of the market.
Competitive Landscape
The report provides both, qualitative and quantitative research of global blue biotechnology market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the global blue biotechnology market are
- AKER BIOMARINE
- Givaudan
- GlycoMar
- INTERDERMA
- LAGOSTA
- Marinova
- New England Biolabs (UK) Ltd.
- PML Applcations
- Samudra Biopharma Pvt. Ltd
- Sanosil Biotech
- Other Market Participants
Global Blue Biotechnology Market:
By Product
- Oil
- Functional Ingredient and animal feed
- Pharmaceuticals and Nutraceuticals
- Foods and food additives
- Cosmetics
- Materials (e.g. clothes and construction materials)
- Energy
- Others
By Usage
- Human
- Pets
- Aquaculture
By Application
- Bio-Engineering
- Drug Discovery
- Genomics
- Vaccines
- Others
By End Users
- Hospitals
- Research and Academic Institutes
- Biotechnology and Pharmaceutical Institutes
- Laboratories
- Others
By Region
- North America (U.S., Canada, Mexico, Rest of North America)
- Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe
- Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific
- Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
- Latin America (Brazil, Argentina, Rest of Latin America)
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 221
1.2.2. Base
Year: 2022
1.2.3. Forecast
Years: 2023 – 2031
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Blue Biotechnology Market
6. Market Synopsis: Blue
Biotechnology Market
7. Blue Biotechnology Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.2.4. Challenges
7.3. Trends in
Blue Biotechnology Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Blue Biotechnology Market
7.6. Porter’s
Five Force Analysis
7.7. Impact of Covid-19
on Blue Biotechnology Market
8. Global Blue Biotechnology Market Analysis and Forecasts, 2023
– 2031
8.1. Overview
8.1.1. Global
Blue Biotechnology Market Revenue (US$ Mn)
8.2. Global
Blue Biotechnology Market Revenue (US$ Mn) and Forecasts, By Product
8.2.1. Oil
8.2.1.1. Definition
8.2.1.2. Market Estimation and Penetration, 2015 - 2022
8.2.1.3. Market Forecast, 2023 – 2031
8.2.1.4. Compound Annual Growth Rate (CAGR)
8.2.1.5. Regional Bifurcation
8.2.1.5.1. North America
8.2.1.5.1.1. Market
Estimation, 2015 - 2022
8.2.1.5.1.2. Market
Forecast, 2023 – 2031
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2015 - 2022
8.2.1.5.2.2. Market
Forecast, 2023 – 2031
8.2.1.5.3. Asia Pacific
8.2.1.5.3.1. Market
Estimation, 2015 - 2022
8.2.1.5.3.2. Market
Forecast, 2023 – 2031
8.2.1.5.4. Middle East and Africa
8.2.1.5.4.1. Market
Estimation, 2015 - 2022
8.2.1.5.4.2. Market
Forecast, 2023 – 2031
8.2.1.5.5. Latin America
8.2.1.5.5.1. Market
Estimation, 2015 - 2022
8.2.1.5.5.2. Market
Forecast, 2023 – 2031
8.2.2. Enzymes
8.2.2.1. Definition
8.2.2.2. Market Estimation and Penetration, 2015 - 2022
8.2.2.3. Market Forecast, 2023 – 2031
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.2.5. Regional Bifurcation
8.2.2.5.1. North America
8.2.2.5.1.1. Market
Estimation, 2015 - 2022
8.2.2.5.1.2. Market
Forecast, 2023 – 2031
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 - 2022
8.2.2.5.2.2. Market
Forecast, 2023 – 2031
8.2.2.5.3. Asia Pacific
8.2.2.5.3.1. Market
Estimation, 2015 - 2022
8.2.2.5.3.2. Market
Forecast, 2023 – 2031
8.2.2.5.4. Middle East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 - 2022
8.2.2.5.4.2. Market
Forecast, 2023 – 2031
8.2.2.5.5. Latin America
8.2.2.5.5.1. Market
Estimation, 2015 - 2022
8.2.2.5.5.2. Market
Forecast, 2023 – 2031
8.2.3. Functional
ingredient and animal feed
8.2.3.1. Definition
8.2.3.2. Market Estimation and Penetration, 2015 - 2022
8.2.3.3. Market Forecast, 2023 – 2031
8.2.3.4. Compound Annual Growth Rate (CAGR)
8.2.3.5. Regional Bifurcation
8.2.3.5.1. North America
8.2.3.5.1.1. Market
Estimation, 2015 - 2022
8.2.3.5.1.2. Market
Forecast, 2023 – 2031
8.2.3.5.2. Europe
8.2.3.5.2.1. Market
Estimation, 2015 - 2022
8.2.3.5.2.2. Market
Forecast, 2023 – 2031
8.2.3.5.3. Asia Pacific
8.2.3.5.3.1. Market
Estimation, 2015 - 2022
8.2.3.5.3.2. Market
Forecast, 2023 – 2031
8.2.3.5.4. Middle East and Africa
8.2.3.5.4.1. Market
Estimation, 2015 - 2022
8.2.3.5.4.2. Market
Forecast, 2023 – 2031
8.2.3.5.5. Latin America
8.2.3.5.5.1. Market
Estimation, 2015 - 2022
8.2.3.5.5.2. Market
Forecast, 2023 – 2031
8.2.4. Pharmaceuticals
and Nutraceuticals
8.2.4.1. Definition
8.2.4.2. Market Estimation and Penetration, 2015 - 2022
8.2.4.3. Market Forecast, 2023 – 2031
8.2.4.4. Compound Annual Growth Rate (CAGR)
8.2.4.5. Regional Bifurcation
8.2.4.5.1. North America
8.2.4.5.1.1. Market
Estimation, 2015 - 2022
8.2.4.5.1.2. Market
Forecast, 2023 – 2031
8.2.4.5.2. Europe
8.2.4.5.2.1. Market
Estimation, 2015 - 2022
8.2.4.5.2.2. Market
Forecast, 2023 – 2031
8.2.4.5.3. Asia Pacific
8.2.4.5.3.1. Market
Estimation, 2015 - 2022
8.2.4.5.3.2. Market
Forecast, 2023 – 2031
8.2.4.5.4. Middle East and Africa
8.2.4.5.4.1. Market
Estimation, 2015 - 2022
8.2.4.5.4.2. Market
Forecast, 2023 – 2031
8.2.4.5.5. Latin America
8.2.4.5.5.1. Market
Estimation, 2015 - 2022
8.2.4.5.5.2. Market
Forecast, 2023 – 2031
8.2.5. Foods
and food additives
8.2.5.1. Definition
8.2.5.2. Market Estimation and Penetration, 2015 - 2022
8.2.5.3. Market Forecast, 2023 – 2031
8.2.5.4. Compound Annual Growth Rate (CAGR)
8.2.5.5. Regional Bifurcation
8.2.5.5.1. North America
8.2.5.5.1.1. Market
Estimation, 2015 - 2022
8.2.5.5.1.2. Market
Forecast, 2023 – 2031
8.2.5.5.2. Europe
8.2.5.5.2.1. Market
Estimation, 2015 - 2022
8.2.5.5.2.2. Market
Forecast, 2023 – 2031
8.2.5.5.3. Asia Pacific
8.2.5.5.3.1. Market
Estimation, 2015 - 2022
8.2.5.5.3.2. Market
Forecast, 2023 – 2031
8.2.5.5.4. Middle East and Africa
8.2.5.5.4.1. Market
Estimation, 2015 - 2022
8.2.5.5.4.2. Market
Forecast, 2023 – 2031
8.2.5.5.5. Latin America
8.2.5.5.5.1. Market
Estimation, 2015 - 2022
8.2.5.5.5.2. Market
Forecast, 2023 – 2031
8.2.6. Cosmetics
8.2.6.1. Definition
8.2.6.2. Market Estimation and Penetration, 2015 - 2022
8.2.6.3. Market Forecast, 2023 – 2031
8.2.6.4. Compound Annual Growth Rate (CAGR)
8.2.6.5. Regional Bifurcation
8.2.6.5.1. North America
8.2.6.5.1.1. Market
Estimation, 2015 - 2022
8.2.6.5.1.2. Market
Forecast, 2023 – 2031
8.2.6.5.2. Europe
8.2.6.5.2.1. Market
Estimation, 2015 - 2022
8.2.6.5.2.2. Market
Forecast, 2023 – 2031
8.2.6.5.3. Asia Pacific
8.2.6.5.3.1. Market
Estimation, 2015 - 2022
8.2.6.5.3.2. Market
Forecast, 2023 – 2031
8.2.6.5.4. Middle East and Africa
8.2.6.5.4.1. Market
Estimation, 2015 - 2022
8.2.6.5.4.2. Market
Forecast, 2023 – 2031
8.2.6.5.5. Latin America
8.2.6.5.5.1. Market
Estimation, 2015 - 2022
8.2.6.5.5.2. Market
Forecast, 2023 – 2031
8.2.7. Materials
(e.g. clothes and construction materials
8.2.7.1. Definition
8.2.7.2. Market Estimation and Penetration, 2015 - 2022
8.2.7.3. Market Forecast, 2023 – 2031
8.2.7.4. Compound Annual Growth Rate (CAGR)
8.2.7.5. Regional Bifurcation
8.2.7.5.1. North America
8.2.7.5.1.1. Market
Estimation, 2015 - 2022
8.2.7.5.1.2. Market
Forecast, 2023 – 2031
8.2.7.5.2. Europe
8.2.7.5.2.1. Market
Estimation, 2015 - 2022
8.2.7.5.2.2. Market
Forecast, 2023 – 2031
8.2.7.5.3. Asia Pacific
8.2.7.5.3.1. Market
Estimation, 2015 - 2022
8.2.7.5.3.2. Market
Forecast, 2023 – 2031
8.2.7.5.4. Middle East and Africa
8.2.7.5.4.1. Market
Estimation, 2015 - 2022
8.2.7.5.4.2. Market
Forecast, 2023 – 2031
8.2.7.5.5. Latin America
8.2.7.5.5.1. Market
Estimation, 2015 - 2022
8.2.7.5.5.2. Market
Forecast, 2023 – 2031
8.2.8. Energy
8.2.8.1. Definition
8.2.8.2. Market Estimation and Penetration, 2015 - 2022
8.2.8.3. Market Forecast, 2023 – 2031
8.2.8.4. Compound Annual Growth Rate (CAGR)
8.2.8.5. Regional Bifurcation
8.2.8.5.1. North America
8.2.8.5.1.1. Market
Estimation, 2015 - 2022
8.2.8.5.1.2. Market
Forecast, 2023 – 2031
8.2.8.5.2. Europe
8.2.8.5.2.1. Market
Estimation, 2015 - 2022
8.2.8.5.2.2. Market
Forecast, 2023 – 2031
8.2.8.5.3. Asia Pacific
8.2.8.5.3.1. Market
Estimation, 2015 - 2022
8.2.8.5.3.2. Market
Forecast, 2023 – 2031
8.2.8.5.4. Middle East and Africa
8.2.8.5.4.1. Market
Estimation, 2015 - 2022
8.2.8.5.4.2. Market
Forecast, 2023 – 2031
8.2.8.5.5. Latin America
8.2.8.5.5.1. Market
Estimation, 2015 - 2022
8.2.8.5.5.2. Market
Forecast, 2023 – 2031
8.2.9. Others
8.2.9.1. Definition
8.2.9.2. Market Estimation and Penetration, 2015 - 2022
8.2.9.3. Market Forecast, 2023 – 2031
8.2.9.4. Compound Annual Growth Rate (CAGR)
8.2.9.5. Regional Bifurcation
8.2.9.5.1. North America
8.2.9.5.1.1. Market
Estimation, 2015 - 2022
8.2.9.5.1.2. Market
Forecast, 2023 – 2031
8.2.9.5.2. Europe
8.2.9.5.2.1. Market
Estimation, 2015 - 2022
8.2.9.5.2.2. Market
Forecast, 2023 – 2031
8.2.9.5.3. Asia Pacific
8.2.9.5.3.1. Market
Estimation, 2015 - 2022
8.2.9.5.3.2. Market
Forecast, 2023 – 2031
8.2.9.5.4. Middle East and Africa
8.2.9.5.4.1. Market
Estimation, 2015 - 2022
8.2.9.5.4.2. Market
Forecast, 2023 – 2031
8.2.9.5.5. Latin America
8.2.9.5.5.1. Market
Estimation, 2015 - 2022
8.2.9.5.5.2. Market
Forecast, 2023 – 2031
8.3. Key
Segment for Channeling Investments
8.3.1. By
Product
9. Global Blue Biotechnology Market Analysis and Forecasts, 2023
– 2031
9.1. Overview
9.2. Global
Blue Biotechnology Market Revenue (US$ Mn) and Forecasts, By Usage
9.2.1. Human
9.2.1.1. Definition
9.2.1.2. Market Estimation and Penetration, 2015 - 2022
9.2.1.3. Market Forecast, 2023 – 2031
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. North America
9.2.1.5.1.1. Market
Estimation, 2015 - 2022
9.2.1.5.1.2. Market
Forecast, 2023 – 2031
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 - 2022
9.2.1.5.2.2. Market
Forecast, 2023 – 2031
9.2.1.5.3. Asia Pacific
9.2.1.5.3.1. Market
Estimation, 2015 - 2022
9.2.1.5.3.2. Market
Forecast, 2023 – 2031
9.2.1.5.4. Middle East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 - 2022
9.2.1.5.4.2. Market
Forecast, 2023 – 2031
9.2.1.5.5. Latin America
9.2.1.5.5.1. Market
Estimation, 2015 - 2022
9.2.1.5.5.2. Market
Forecast, 2023 – 2031
9.2.2. Pets
9.2.2.1. Definition
9.2.2.2. Market Estimation and Penetration, 2015 - 2022
9.2.2.3. Market Forecast, 2023 – 2031
9.2.2.4. Compound Annual Growth Rate (CAGR)
9.2.2.5. Regional Bifurcation
9.2.2.5.1. North America
9.2.2.5.1.1. Market
Estimation, 2015 - 2022
9.2.2.5.1.2. Market
Forecast, 2023 – 2031
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 - 2022
9.2.2.5.2.2. Market
Forecast, 2023 – 2031
9.2.2.5.3. Asia Pacific
9.2.2.5.3.1. Market
Estimation, 2015 - 2022
9.2.2.5.3.2. Market
Forecast, 2023 – 2031
9.2.2.5.4. Middle East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 - 2022
9.2.2.5.4.2. Market
Forecast, 2023 – 2031
9.2.2.5.5. Latin America
9.2.2.5.5.1. Market
Estimation, 2015 - 2022
9.2.2.5.5.2. Market
Forecast, 2023 – 2031
9.2.3. Aquaculture
9.2.3.1. Definition
9.2.3.2. Market Estimation and Penetration, 2015 - 2022
9.2.3.3. Market Forecast, 2023 – 2031
9.2.3.4. Compound Annual Growth Rate (CAGR)
9.2.3.5. Regional Bifurcation
9.2.3.5.1. North America
9.2.3.5.1.1. Market
Estimation, 2015 - 2022
9.2.3.5.1.2. Market
Forecast, 2023 – 2031
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2015 - 2022
9.2.3.5.2.2. Market
Forecast, 2023 – 2031
9.2.3.5.3. Asia Pacific
9.2.3.5.3.1. Market
Estimation, 2015 - 2022
9.2.3.5.3.2. Market
Forecast, 2023 – 2031
9.2.3.5.4. Middle East and Africa
9.2.3.5.4.1. Market
Estimation, 2015 - 2022
9.2.3.5.4.2. Market
Forecast, 2023 – 2031
9.2.3.5.5. Latin America
9.2.3.5.5.1. Market
Estimation, 2015 - 2022
9.2.3.5.5.2. Market
Forecast, 2023 – 2031
9.3. Key
Segment for Channeling Investments
9.3.1. By Usage
10. Global Blue Biotechnology Market Analysis and Forecasts, 2023
– 2031
10.1. Overview
10.2. Global
Blue Biotechnology Market Revenue (US$ Mn) and Forecasts, By Application
10.2.1. Bio-
Engineering
10.2.1.1. Definition
10.2.1.2. Market Estimation and Penetration, 2015 - 2022
10.2.1.3. Market Forecast, 2023 – 2031
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1. Market
Estimation, 2015 - 2022
10.2.1.5.1.2. Market
Forecast, 2023 – 2031
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 - 2022
10.2.1.5.2.2. Market
Forecast, 2023 – 2031
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1. Market
Estimation, 2015 - 2022
10.2.1.5.3.2. Market
Forecast, 2023 – 2031
10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 - 2022
10.2.1.5.4.2. Market
Forecast, 2023 – 2031
10.2.1.5.5. Latin America
10.2.1.5.5.1. Market
Estimation, 2015 - 2022
10.2.1.5.5.2. Market
Forecast, 2023 – 2031
10.2.2. Drug Discovery
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 - 2022
10.2.2.3. Market Forecast, 2023 – 2031
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market
Estimation, 2015 - 2022
10.2.2.5.1.2. Market
Forecast, 2023 – 2031
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 - 2022
10.2.2.5.2.2. Market
Forecast, 2023 – 2031
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market
Estimation, 2015 - 2022
10.2.2.5.3.2. Market
Forecast, 2023 – 2031
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 - 2022
10.2.2.5.4.2. Market
Forecast, 2023 – 2031
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market
Estimation, 2015 - 2022
10.2.2.5.5.2. Market
Forecast, 2023 – 2031
10.2.3. Genomics
10.2.3.1. Definition
10.2.3.2. Market Estimation and Penetration, 2015 - 2022
10.2.3.3. Market Forecast, 2023 – 2031
10.2.3.4. Compound Annual Growth Rate (CAGR)
10.2.3.5. Regional Bifurcation
10.2.3.5.1. North America
10.2.3.5.1.1. Market
Estimation, 2015 - 2022
10.2.3.5.1.2. Market
Forecast, 2023 – 2031
10.2.3.5.2. Europe
10.2.3.5.2.1. Market
Estimation, 2015 - 2022
10.2.3.5.2.2. Market
Forecast, 2023 – 2031
10.2.3.5.3. Asia Pacific
10.2.3.5.3.1. Market
Estimation, 2015 - 2022
10.2.3.5.3.2. Market
Forecast, 2023 – 2031
10.2.3.5.4. Middle East and Africa
10.2.3.5.4.1. Market
Estimation, 2015 - 2022
10.2.3.5.4.2. Market
Forecast, 2023 – 2031
10.2.3.5.5. Latin America
10.2.3.5.5.1. Market
Estimation, 2015 - 2022
10.2.3.5.5.2. Market
Forecast, 2023 – 2031
10.2.4. Vaccines
10.2.4.1. Definition
10.2.4.2. Market Estimation and Penetration, 2015 - 2022
10.2.4.3. Market Forecast, 2023 – 2031
10.2.4.4. Compound Annual Growth Rate (CAGR)
10.2.4.5. Regional Bifurcation
10.2.4.5.1. North America
10.2.4.5.1.1. Market
Estimation, 2015 - 2022
10.2.4.5.1.2. Market
Forecast, 2023 – 2031
10.2.4.5.2. Europe
10.2.4.5.2.1. Market
Estimation, 2015 - 2022
10.2.4.5.2.2. Market
Forecast, 2023 – 2031
10.2.4.5.3. Asia Pacific
10.2.4.5.3.1. Market
Estimation, 2015 - 2022
10.2.4.5.3.2. Market
Forecast, 2023 – 2031
10.2.4.5.4. Middle East and Africa
10.2.4.5.4.1. Market
Estimation, 2015 - 2022
10.2.4.5.4.2. Market
Forecast, 2023 – 2031
10.2.4.5.5. Latin America
10.2.4.5.5.1. Market
Estimation, 2015 - 2022
10.2.4.5.5.2. Market
Forecast, 2023 – 2031
10.2.5. Others
10.2.5.1. Definition
10.2.5.2. Market Estimation and Penetration, 2015 - 2022
10.2.5.3. Market Forecast, 2023 – 2031
10.2.5.4. Compound Annual Growth Rate (CAGR)
10.2.5.5. Regional Bifurcation
10.2.5.5.1. North America
10.2.5.5.1.1. Market
Estimation, 2015 - 2022
10.2.5.5.1.2. Market
Forecast, 2023 – 2031
10.2.5.5.2. Europe
10.2.5.5.2.1. Market
Estimation, 2015 - 2022
10.2.5.5.2.2. Market
Forecast, 2023 – 2031
10.2.5.5.3. Asia Pacific
10.2.5.5.3.1. Market
Estimation, 2015 - 2022
10.2.5.5.3.2. Market
Forecast, 2023 – 2031
10.2.5.5.4. Middle East and Africa
10.2.5.5.4.1. Market
Estimation, 2015 - 2022
10.2.5.5.4.2. Market
Forecast, 2023 – 2031
10.2.5.5.5. Latin America
10.2.5.5.5.1. Market
Estimation, 2015 - 2022
10.2.5.5.5.2. Market
Forecast, 2023 – 2031
10.3. Key
Segment for Channeling Investments
10.3.1. By
Application
11. Global Blue Biotechnology Market Analysis and Forecasts, 2023
– 2031
11.1. Overview
11.2. Global
Blue Biotechnology Market Revenue (US$ Mn) and Forecasts, By End Users
11.2.1. Hospitals
11.2.1.1. Definition
11.2.1.2. Market Estimation and Penetration, 2015 - 2022
11.2.1.3. Market Forecast, 2023 – 2031
11.2.1.4. Compound Annual Growth Rate (CAGR)
11.2.1.5. Regional Bifurcation
11.2.1.5.1. North America
11.2.1.5.1.1. Market
Estimation, 2015 - 2022
11.2.1.5.1.2. Market
Forecast, 2023 – 2031
11.2.1.5.2. Europe
11.2.1.5.2.1. Market
Estimation, 2015 - 2022
11.2.1.5.2.2. Market
Forecast, 2023 – 2031
11.2.1.5.3. Asia Pacific
11.2.1.5.3.1. Market
Estimation, 2015 - 2022
11.2.1.5.3.2. Market
Forecast, 2023 – 2031
11.2.1.5.4. Middle East and Africa
11.2.1.5.4.1. Market
Estimation, 2015 - 2022
11.2.1.5.4.2. Market
Forecast, 2023 – 2031
11.2.1.5.5. Latin America
11.2.1.5.5.1. Market
Estimation, 2015 - 2022
11.2.1.5.5.2. Market
Forecast, 2023 – 2031
11.2.2. Research
and Academic Institutes
11.2.2.1. Definition
11.2.2.2. Market Estimation and Penetration, 2015 - 2022
11.2.2.3. Market Forecast, 2023 – 2031
11.2.2.4. Compound Annual Growth Rate (CAGR)
11.2.2.5. Regional Bifurcation
11.2.2.5.1. North America
11.2.2.5.1.1. Market
Estimation, 2015 - 2022
11.2.2.5.1.2. Market
Forecast, 2023 – 2031
11.2.2.5.2. Europe
11.2.2.5.2.1. Market
Estimation, 2015 - 2022
11.2.2.5.2.2. Market
Forecast, 2023 – 2031
11.2.2.5.3. Asia Pacific
11.2.2.5.3.1. Market
Estimation, 2015 - 2022
11.2.2.5.3.2. Market
Forecast, 2023 – 2031
11.2.2.5.4. Middle East and Africa
11.2.2.5.4.1. Market
Estimation, 2015 - 2022
11.2.2.5.4.2. Market
Forecast, 2023 – 2031
11.2.2.5.5. Latin America
11.2.2.5.5.1. Market
Estimation, 2015 - 2022
11.2.2.5.5.2. Market
Forecast, 2023 – 2031
11.2.3. Biotechnology
and Pharmaceutical Institutes
11.2.3.1. Definition
11.2.3.2. Market Estimation and Penetration, 2015 - 2022
11.2.3.3. Market Forecast, 2023 – 2031
11.2.3.4. Compound Annual Growth Rate (CAGR)
11.2.3.5. Regional Bifurcation
11.2.3.5.1. North America
11.2.3.5.1.1. Market
Estimation, 2015 - 2022
11.2.3.5.1.2. Market
Forecast, 2023 – 2031
11.2.3.5.2. Europe
11.2.3.5.2.1. Market
Estimation, 2015 - 2022
11.2.3.5.2.2. Market
Forecast, 2023 – 2031
11.2.3.5.3. Asia Pacific
11.2.3.5.3.1. Market
Estimation, 2015 - 2022
11.2.3.5.3.2. Market
Forecast, 2023 – 2031
11.2.3.5.4. Middle East and Africa
11.2.3.5.4.1. Market
Estimation, 2015 - 2022
11.2.3.5.4.2. Market
Forecast, 2023 – 2031
11.2.3.5.5. Latin America
11.2.3.5.5.1. Market
Estimation, 2015 - 2022
11.2.3.5.5.2. Market
Forecast, 2023 – 2031
11.2.4. Laboratories
11.2.4.1. Definition
11.2.4.2. Market Estimation and Penetration, 2015 - 2022
11.2.4.3. Market Forecast, 2023 – 2031
11.2.4.4. Compound Annual Growth Rate (CAGR)
11.2.4.5. Regional Bifurcation
11.2.4.5.1. North America
11.2.4.5.1.1. Market
Estimation, 2015 - 2022
11.2.4.5.1.2. Market
Forecast, 2023 – 2031
11.2.4.5.2. Europe
11.2.4.5.2.1. Market
Estimation, 2015 - 2022
11.2.4.5.2.2. Market
Forecast, 2023 – 2031
11.2.4.5.3. Asia Pacific
11.2.4.5.3.1. Market
Estimation, 2015 - 2022
11.2.4.5.3.2. Market
Forecast, 2023 – 2031
11.2.4.5.4. Middle East and Africa
11.2.4.5.4.1. Market
Estimation, 2015 - 2022
11.2.4.5.4.2. Market
Forecast, 2023 – 2031
11.2.4.5.5. Latin America
11.2.4.5.5.1. Market
Estimation, 2015 - 2022
11.2.4.5.5.2. Market
Forecast, 2023 – 2031
11.2.5. Others
11.2.5.1. Definition
11.2.5.2. Market Estimation and Penetration, 2015 - 2022
11.2.5.3. Market Forecast, 2023 – 2031
11.2.5.4. Compound Annual Growth Rate (CAGR)
11.2.5.5. Regional Bifurcation
11.2.5.5.1. North America
11.2.5.5.1.1. Market
Estimation, 2015 - 2022
11.2.5.5.1.2. Market
Forecast, 2023 – 2031
11.2.5.5.2. Europe
11.2.5.5.2.1. Market
Estimation, 2015 - 2022
11.2.5.5.2.2. Market
Forecast, 2023 – 2031
11.2.5.5.3. Asia Pacific
11.2.5.5.3.1. Market
Estimation, 2015 - 2022
11.2.5.5.3.2. Market
Forecast, 2023 – 2031
11.2.5.5.4. Middle East and Africa
11.2.5.5.4.1. Market
Estimation, 2015 - 2022
11.2.5.5.4.2. Market
Forecast, 2023 – 2031
11.2.5.5.5. Latin America
11.2.5.5.5.1. Market
Estimation, 2015 - 2022
11.2.5.5.5.2. Market
Forecast, 2023 – 2031
11.3. Key
Segment for Channeling Investments
11.3.1. By End
Users
12. North America Blue Biotechnology Market Analysis and
Forecasts, 2023 – 2031
12.1. Overview
12.1.1. North
America Blue Biotechnology Market Revenue (US$ Mn)
12.2. North
America Blue Biotechnology Market Revenue (US$ Mn) and Forecasts, By Product
12.2.1. Oil
12.2.2. Enzymes
12.2.3. Functional
ingredient and animal feed
12.2.4. Pharmaceuticals
and Nutraceuticals
12.2.5. Foods
and food additives
12.2.6. Cosmetics
12.2.7. Materials
(e.g. clothes and construction materials
12.2.8. Energy
12.2.9. Others
12.3. North
America Blue Biotechnology Market Revenue (US$ Mn) and Forecasts, By Usage
12.3.1. Human
12.3.2. Pets
12.3.3. Aquaculture
12.4. North
America Blue Biotechnology Market Revenue (US$ Mn) and Forecasts, By
Application
12.4.1. Bio-
Engineering
12.4.2. Drug Discovery
12.4.3. Genomics
12.4.4. Vaccines
12.4.5. Others
12.5. North
America Blue Biotechnology Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.1. Hospitals
12.5.2. Research
and Academic Institutes
12.5.3. Biotechnology
and Pharmaceutical Institutes
12.5.4. Laboratories
12.5.5. Others
12.6. North
America Blue Biotechnology Market Revenue (US$ Mn) and Forecasts, By Country
12.6.1. U.S
12.6.1.1. U.S Blue Biotechnology Market Revenue (US$ Mn) and Forecasts,
By Product
12.6.1.1.1. Oil
12.6.1.1.2. Enzymes
12.6.1.1.3. Functional ingredient and animal feed
12.6.1.1.4. Pharmaceuticals and Nutraceuticals
12.6.1.1.5. Foods and food additives
12.6.1.1.6. Cosmetics
12.6.1.1.7. Materials (e.g. clothes and construction materials
12.6.1.1.8. Energy
12.6.1.1.9. Others
12.6.1.2. U.S Blue Biotechnology Market Revenue (US$ Mn) and Forecasts,
By Usage
12.6.1.2.1. Human
12.6.1.2.2. Pets
12.6.1.2.3. Aquaculture
12.6.1.3. U.S Blue Biotechnology Market Revenue (US$ Mn) and Forecasts,
By Application
12.6.1.3.1. Bio- Engineering
12.6.1.3.2. Drug Discovery
12.6.1.3.3. Genomics
12.6.1.3.4. Vaccines
12.6.1.3.5. Others
12.6.1.4. U.S Blue Biotechnology Market Revenue (US$ Mn) and Forecasts,
By End Users
12.6.1.4.1. Hospitals
12.6.1.4.2. Research and Academic Institutes
12.6.1.4.3. Biotechnology and Pharmaceutical Institutes
12.6.1.4.4. Laboratories
12.6.1.4.5. Others
12.6.2. Canada
12.6.2.1. Canada Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Product
12.6.2.1.1. Oil
12.6.2.1.2. Enzymes
12.6.2.1.3. Functional ingredient and animal feed
12.6.2.1.4. Pharmaceuticals and Nutraceuticals
12.6.2.1.5. Foods and food additives
12.6.2.1.6. Cosmetics
12.6.2.1.7. Materials (e.g. clothes and construction materials
12.6.2.1.8. Energy
12.6.2.1.9. Others
12.6.2.2. Canada Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Usage
12.6.2.2.1. Human
12.6.2.2.2. Pets
12.6.2.2.3. Aquaculture
12.6.2.3. Canada Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Application
12.6.2.3.1. Bio- Engineering
12.6.2.3.2. Drug Discovery
12.6.2.3.3. Genomics
12.6.2.3.4. Vaccines
12.6.2.3.5. Others
12.6.2.4. Canada Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By End Users
12.6.2.4.1. Hospitals
12.6.2.4.2. Research and Academic Institutes
12.6.2.4.3. Biotechnology and Pharmaceutical Institutes
12.6.2.4.4. Laboratories
12.6.2.4.5. Others
12.6.3. Mexico
12.6.3.1. Mexico Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Product
12.6.3.1.1. Oil
12.6.3.1.2. Enzymes
12.6.3.1.3. Functional ingredient and animal feed
12.6.3.1.4. Pharmaceuticals and Nutraceuticals
12.6.3.1.5. Foods and food additives
12.6.3.1.6. Cosmetics
12.6.3.1.7. Materials (e.g. clothes and construction materials
12.6.3.1.8. Energy
12.6.3.1.9. Others
12.6.3.2. Mexico Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Usage
12.6.3.2.1. Human
12.6.3.2.2. Pets
12.6.3.2.3. Aquaculture
12.6.3.3. Mexico Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Application
12.6.3.3.1. Bio- Engineering
12.6.3.3.2. Drug Discovery
12.6.3.3.3. Genomics
12.6.3.3.4. Vaccines
12.6.3.3.5. Others
12.6.3.4. Mexico Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By End Users
12.6.3.4.1. Hospitals
12.6.3.4.2. Research and Academic Institutes
12.6.3.4.3. Biotechnology and Pharmaceutical Institutes
12.6.3.4.4. Laboratories
12.6.3.4.5. Others
12.6.4. Rest of
North America
12.6.4.1. Rest of North America Blue Biotechnology Market Revenue (US$
Mn) and Forecasts, By Product
12.6.4.1.1. Oil
12.6.4.1.2. Enzymes
12.6.4.1.3. Functional ingredient and animal feed
12.6.4.1.4. Pharmaceuticals and Nutraceuticals
12.6.4.1.5. Foods and food additives
12.6.4.1.6. Cosmetics
12.6.4.1.7. Materials (e.g. clothes and construction materials
12.6.4.1.8. Energy
12.6.4.1.9. Others
12.6.4.2. Rest of North America Blue Biotechnology Market Revenue (US$
Mn) and Forecasts, By Usage
12.6.4.2.1. Human
12.6.4.2.2. Pets
12.6.4.2.3. Aquaculture
12.6.4.3. Rest of North America Blue Biotechnology Market Revenue (US$
Mn) and Forecasts, By Application
12.6.4.3.1. Bio- Engineering
12.6.4.3.2. Drug Discovery
12.6.4.3.3. Genomics
12.6.4.3.4. Vaccines
12.6.4.3.5. Others
12.6.4.4. Rest of North America Blue Biotechnology Market Revenue (US$
Mn) and Forecasts, By End Users
12.6.4.4.1. Hospitals
12.6.4.4.2. Research and Academic Institutes
12.6.4.4.3. Biotechnology and Pharmaceutical Institutes
12.6.4.4.4. Laboratories
12.6.4.4.5. Others
12.7. Key
Segment for Channeling Investments
12.7.1. By
Country
12.7.2. By
Product
12.7.3. By
Usage
12.7.4. By Application
12.7.5. By End
Users
13. Europe Blue Biotechnology Market Analysis and Forecasts, 2023
– 2031
13.1. Overview
13.1.1. Europe
Blue Biotechnology Market Revenue (US$ Mn)
13.2. Europe
Blue Biotechnology Market Revenue (US$ Mn) and Forecasts, By Product
13.2.1. Oil
13.2.2. Enzymes
13.2.3. Functional
ingredient and animal feed
13.2.4. Pharmaceuticals
and Nutraceuticals
13.2.5. Foods
and food additives
13.2.6. Cosmetics
13.2.7. Materials
(e.g. clothes and construction materials
13.2.8. Energy
13.2.9. Others
13.3. Europe
Blue Biotechnology Market Revenue (US$ Mn) and Forecasts, By Usage
13.3.1. Human
13.3.2. Pets
13.3.3. Aquaculture
13.4. Europe
Blue Biotechnology Market Revenue (US$ Mn) and Forecasts, By Application
13.4.1. Bio-
Engineering
13.4.2. Drug Discovery
13.4.3. Genomics
13.4.4. Vaccines
13.4.5. Others
13.5. Europe
Blue Biotechnology Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.1. Hospitals
13.5.2. Research
and Academic Institutes
13.5.3. Biotechnology
and Pharmaceutical Institutes
13.5.4. Laboratories
13.5.5. Others
13.6. Europe
Blue Biotechnology Market Revenue (US$ Mn) and Forecasts, By Country
13.6.1. France
13.6.1.1. France Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Product
13.6.1.1.1. Oil
13.6.1.1.2. Enzymes
13.6.1.1.3. Functional ingredient and animal feed
13.6.1.1.4. Pharmaceuticals and Nutraceuticals
13.6.1.1.5. Foods and food additives
13.6.1.1.6. Cosmetics
13.6.1.1.7. Materials (e.g. clothes and construction materials
13.6.1.1.8. Energy
13.6.1.1.9. Others
13.6.1.2. France Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Usage
13.6.1.2.1. Human
13.6.1.2.2. Pets
13.6.1.2.3. Aquaculture
13.6.1.3. France Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.1.3.1. Bio- Engineering
13.6.1.3.2. Drug Discovery
13.6.1.3.3. Genomics
13.6.1.3.4. Vaccines
13.6.1.3.5. Others
13.6.1.4. France Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By End Users
13.6.1.4.1. Hospitals
13.6.1.4.2. Research and Academic Institutes
13.6.1.4.3. Biotechnology and Pharmaceutical Institutes
13.6.1.4.4. Laboratories
13.6.1.4.5. Others
13.6.2. The UK
13.6.2.1. The UK Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Product
13.6.2.1.1. Oil
13.6.2.1.2. Enzymes
13.6.2.1.3. Functional ingredient and animal feed
13.6.2.1.4. Pharmaceuticals and Nutraceuticals
13.6.2.1.5. Foods and food additives
13.6.2.1.6. Cosmetics
13.6.2.1.7. Materials (e.g. clothes and construction materials
13.6.2.1.8. Energy
13.6.2.1.9. Others
13.6.2.2. The UK Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Usage
13.6.2.2.1. Human
13.6.2.2.2. Pets
13.6.2.2.3. Aquaculture
13.6.2.3. The UK Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.2.3.1. Bio- Engineering
13.6.2.3.2. Drug Discovery
13.6.2.3.3. Genomics
13.6.2.3.4. Vaccines
13.6.2.3.5. Others
13.6.2.4. The UK Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By End Users
13.6.2.4.1. Hospitals
13.6.2.4.2. Research and Academic Institutes
13.6.2.4.3. Biotechnology and Pharmaceutical Institutes
13.6.2.4.4. Laboratories
13.6.2.4.5. Others
13.6.3. Spain
13.6.3.1. Spain Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Product
13.6.3.1.1. Oil
13.6.3.1.2. Enzymes
13.6.3.1.3. Functional ingredient and animal feed
13.6.3.1.4. Pharmaceuticals and Nutraceuticals
13.6.3.1.5. Foods and food additives
13.6.3.1.6. Cosmetics
13.6.3.1.7. Materials (e.g. clothes and construction materials
13.6.3.1.8. Energy
13.6.3.1.9. Others
13.6.3.2. Spain Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Usage
13.6.3.2.1. Human
13.6.3.2.2. Pets
13.6.3.2.3. Aquaculture
13.6.3.3. Spain Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.3.3.1. Bio- Engineering
13.6.3.3.2. Drug Discovery
13.6.3.3.3. Genomics
13.6.3.3.4. Vaccines
13.6.3.3.5. Others
13.6.3.4. Spain Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By End Users
13.6.3.4.1. Hospitals
13.6.3.4.2. Research and Academic Institutes
13.6.3.4.3. Biotechnology and Pharmaceutical Institutes
13.6.3.4.4. Laboratories
13.6.3.4.5. Others
13.6.4. Germany
13.6.4.1. Germany Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Product
13.6.4.1.1. Oil
13.6.4.1.2. Enzymes
13.6.4.1.3. Functional ingredient and animal feed
13.6.4.1.4. Pharmaceuticals and Nutraceuticals
13.6.4.1.5. Foods and food additives
13.6.4.1.6. Cosmetics
13.6.4.1.7. Materials (e.g. clothes and construction materials
13.6.4.1.8. Energy
13.6.4.1.9. Others
13.6.4.2. Germany Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Usage
13.6.4.2.1. Human
13.6.4.2.2. Pets
13.6.4.2.3. Aquaculture
13.6.4.3. Germany Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.4.3.1. Bio- Engineering
13.6.4.3.2. Drug Discovery
13.6.4.3.3. Genomics
13.6.4.3.4. Vaccines
13.6.4.3.5. Others
13.6.4.4. Germany Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By End Users
13.6.4.4.1. Hospitals
13.6.4.4.2. Research and Academic Institutes
13.6.4.4.3. Biotechnology and Pharmaceutical Institutes
13.6.4.4.4. Laboratories
13.6.4.4.5. Others
13.6.5. Italy
13.6.5.1. Italy Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Product
13.6.5.1.1. Oil
13.6.5.1.2. Enzymes
13.6.5.1.3. Functional ingredient and animal feed
13.6.5.1.4. Pharmaceuticals and Nutraceuticals
13.6.5.1.5. Foods and food additives
13.6.5.1.6. Cosmetics
13.6.5.1.7. Materials (e.g. clothes and construction materials
13.6.5.1.8. Energy
13.6.5.1.9. Others
13.6.5.2. Italy Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Usage
13.6.5.2.1. Human
13.6.5.2.2. Pets
13.6.5.2.3. Aquaculture
13.6.5.3. Italy Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.5.3.1. Bio- Engineering
13.6.5.3.2. Drug Discovery
13.6.5.3.3. Genomics
13.6.5.3.4. Vaccines
13.6.5.3.5. Others
13.6.5.4. Italy Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By End Users
13.6.5.4.1. Hospitals
13.6.5.4.2. Research and Academic Institutes
13.6.5.4.3. Biotechnology and Pharmaceutical Institutes
13.6.5.4.4. Laboratories
13.6.5.4.5. Others
13.6.6. Nordic
Countries
13.6.6.1. Nordic Countries Blue Biotechnology Market Revenue (US$ Mn)
and Forecasts, By Product
13.6.6.1.1. Oil
13.6.6.1.2. Enzymes
13.6.6.1.3. Functional ingredient and animal feed
13.6.6.1.4. Pharmaceuticals and Nutraceuticals
13.6.6.1.5. Foods and food additives
13.6.6.1.6. Cosmetics
13.6.6.1.7. Materials (e.g. clothes and construction materials
13.6.6.1.8. Energy
13.6.6.1.9. Others
13.6.6.2. Nordic Countries Blue Biotechnology Market Revenue (US$ Mn)
and Forecasts, By Usage
13.6.6.2.1. Human
13.6.6.2.2. Pets
13.6.6.2.3. Aquaculture
13.6.6.3. Nordic Countries Blue Biotechnology Market Revenue (US$ Mn)
and Forecasts, By Application
13.6.6.3.1. Bio- Engineering
13.6.6.3.2. Drug Discovery
13.6.6.3.3. Genomics
13.6.6.3.4. Vaccines
13.6.6.3.5. Others
13.6.6.4. Nordic Countries Blue Biotechnology Market Revenue (US$ Mn)
and Forecasts, By End Users
13.6.6.4.1. Hospitals
13.6.6.4.2. Research and Academic Institutes
13.6.6.4.3. Biotechnology and Pharmaceutical Institutes
13.6.6.4.4. Laboratories
13.6.6.4.5. Others
13.6.6.5. Nordic Countries Blue Biotechnology Market Revenue (US$ Mn)
and Forecasts, By Country
13.6.6.5.1. Denmark
13.6.6.5.2. Finland
13.6.6.5.3. Iceland
13.6.6.5.4. Sweden
13.6.6.5.5. Norway
13.6.7. Benelux
Union
13.6.7.1. Benelux Union Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Product
13.6.7.1.1. Oil
13.6.7.1.2. Enzymes
13.6.7.1.3. Functional ingredient and animal feed
13.6.7.1.4. Pharmaceuticals and Nutraceuticals
13.6.7.1.5. Foods and food additives
13.6.7.1.6. Cosmetics
13.6.7.1.7. Materials (e.g. clothes and construction materials
13.6.7.1.8. Energy
13.6.7.1.9. Others
13.6.7.2. Benelux Union Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Usage
13.6.7.2.1. Human
13.6.7.2.2. Pets
13.6.7.2.3. Aquaculture
13.6.7.3. Benelux Union Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.7.3.1. Bio- Engineering
13.6.7.3.2. Drug Discovery
13.6.7.3.3. Genomics
13.6.7.3.4. Vaccines
13.6.7.3.5. Others
13.6.7.4. Benelux Union Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By End Users
13.6.7.4.1. Hospitals
13.6.7.4.2. Research and Academic Institutes
13.6.7.4.3. Biotechnology and Pharmaceutical Institutes
13.6.7.4.4. Laboratories
13.6.7.4.5. Others
13.6.7.5. Benelux Union Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Country
13.6.7.5.1. Belgium
13.6.7.5.2. The Netherlands
13.6.7.5.3. Luxembourg
13.6.8. Rest of
Europe
13.6.8.1. Rest of Europe Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Product
13.6.8.1.1. Oil
13.6.8.1.2. Enzymes
13.6.8.1.3. Functional ingredient and animal feed
13.6.8.1.4. Pharmaceuticals and Nutraceuticals
13.6.8.1.5. Foods and food additives
13.6.8.1.6. Cosmetics
13.6.8.1.7. Materials (e.g. clothes and construction materials
13.6.8.1.8. Energy
13.6.8.1.9. Others
13.6.8.2. Rest of Europe Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Usage
13.6.8.2.1. Human
13.6.8.2.2. Pets
13.6.8.2.3. Aquaculture
13.6.8.3. Rest of Europe Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.8.3.1. Bio- Engineering
13.6.8.3.2. Drug Discovery
13.6.8.3.3. Genomics
13.6.8.3.4. Vaccines
13.6.8.3.5. Others
13.6.8.4. Rest of Europe Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By End Users
13.6.8.4.1. Hospitals
13.6.8.4.2. Research and Academic Institutes
13.6.8.4.3. Biotechnology and Pharmaceutical Institutes
13.6.8.4.4. Laboratories
13.6.8.4.5. Others
13.7. Key
Segment for Channeling Investments
13.7.1. By
Country
13.7.2. By
Product
13.7.3. By
Usage
13.7.4. By
Application
13.7.5. By End
Users
14. Asia Pacific Blue Biotechnology Market Analysis and
Forecasts, 2023 – 2031
14.1. Overview
14.1.1. Asia
Pacific Blue Biotechnology Market Revenue (US$ Mn)
14.2. Asia Pacific
Blue Biotechnology Market Revenue (US$ Mn) and Forecasts, By Product
14.2.1. Oil
14.2.2. Enzymes
14.2.3. Functional
ingredient and animal feed
14.2.4. Pharmaceuticals
and Nutraceuticals
14.2.5. Foods
and food additives
14.2.6. Cosmetics
14.2.7. Materials
(e.g. clothes and construction materials
14.2.8. Energy
14.2.9. Others
14.3. Asia
Pacific Blue Biotechnology Market Revenue (US$ Mn) and Forecasts, By Usage
14.3.1. Human
14.3.2. Pets
14.3.3. Aquaculture
14.4. Asia
Pacific Blue Biotechnology Market Revenue (US$ Mn) and Forecasts, By
Application
14.4.1. Bio-
Engineering
14.4.2. Drug Discovery
14.4.3. Genomics
14.4.4. Vaccines
14.4.5. Others
14.5. Asia
Pacific Blue Biotechnology Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.1. Hospitals
14.5.2. Research
and Academic Institutes
14.5.3. Biotechnology
and Pharmaceutical Institutes
14.5.4. Laboratories
14.5.5. Others
14.6. Asia
Pacific Blue Biotechnology Market Revenue (US$ Mn) and Forecasts, By Country
14.6.1. China
14.6.1.1. China Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Product
14.6.1.1.1. Oil
14.6.1.1.2. Enzymes
14.6.1.1.3. Functional ingredient and animal feed
14.6.1.1.4. Pharmaceuticals and Nutraceuticals
14.6.1.1.5. Foods and food additives
14.6.1.1.6. Cosmetics
14.6.1.1.7. Materials (e.g. clothes and construction materials
14.6.1.1.8. Energy
14.6.1.1.9. Others
14.6.1.2. China Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Usage
14.6.1.2.1. Human
14.6.1.2.2. Pets
14.6.1.2.3. Aquaculture
14.6.1.3. China Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.1.3.1. Bio- Engineering
14.6.1.3.2. Drug Discovery
14.6.1.3.3. Genomics
14.6.1.3.4. Vaccines
14.6.1.3.5. Others
14.6.1.4. China Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By End Users
14.6.1.4.1. Hospitals
14.6.1.4.2. Research and Academic Institutes
14.6.1.4.3. Biotechnology and Pharmaceutical Institutes
14.6.1.4.4. Laboratories
14.6.1.4.5. Others
14.6.2. Japan
14.6.2.1. Japan Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Product
14.6.2.1.1. Oil
14.6.2.1.2. Enzymes
14.6.2.1.3. Functional ingredient and animal feed
14.6.2.1.4. Pharmaceuticals and Nutraceuticals
14.6.2.1.5. Foods and food additives
14.6.2.1.6. Cosmetics
14.6.2.1.7. Materials (e.g. clothes and construction materials
14.6.2.1.8. Energy
14.6.2.1.9. Others
14.6.2.2. Japan Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Usage
14.6.2.2.1. Human
14.6.2.2.2. Pets
14.6.2.2.3. Aquaculture
14.6.2.3. Japan Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.2.3.1. Bio- Engineering
14.6.2.3.2. Drug Discovery
14.6.2.3.3. Genomics
14.6.2.3.4. Vaccines
14.6.2.3.5. Others
14.6.2.4. Japan Blue Biotechnology Market Revenue (US$ Mn) and Forecasts,
By End Users
14.6.2.4.1. Hospitals
14.6.2.4.2. Research and Academic Institutes
14.6.2.4.3. Biotechnology and Pharmaceutical Institutes
14.6.2.4.4. Laboratories
14.6.2.4.5. Others
14.6.3. India
14.6.3.1. India Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Product
14.6.3.1.1. Oil
14.6.3.1.2. Enzymes
14.6.3.1.3. Functional ingredient and animal feed
14.6.3.1.4. Pharmaceuticals and Nutraceuticals
14.6.3.1.5. Foods and food additives
14.6.3.1.6. Cosmetics
14.6.3.1.7. Materials (e.g. clothes and construction materials
14.6.3.1.8. Energy
14.6.3.1.9. Others
14.6.3.2. India Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Usage
14.6.3.2.1. Human
14.6.3.2.2. Pets
14.6.3.2.3. Aquaculture
14.6.3.3. India Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.3.3.1. Bio- Engineering
14.6.3.3.2. Drug Discovery
14.6.3.3.3. Genomics
14.6.3.3.4. Vaccines
14.6.3.3.5. Others
14.6.3.4. India Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By End Users
14.6.3.4.1. Hospitals
14.6.3.4.2. Research and Academic Institutes
14.6.3.4.3. Biotechnology and Pharmaceutical Institutes
14.6.3.4.4. Laboratories
14.6.3.4.5. Others
14.6.4. New
Zealand
14.6.4.1. New Zealand Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Product
14.6.4.1.1. Oil
14.6.4.1.2. Enzymes
14.6.4.1.3. Functional ingredient and animal feed
14.6.4.1.4. Pharmaceuticals and Nutraceuticals
14.6.4.1.5. Foods and food additives
14.6.4.1.6. Cosmetics
14.6.4.1.7. Materials (e.g. clothes and construction materials
14.6.4.1.8. Energy
14.6.4.1.9. Others
14.6.4.2. New Zealand Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Usage
14.6.4.2.1. Human
14.6.4.2.2. Pets
14.6.4.2.3. Aquaculture
14.6.4.3. New Zealand Blue Biotechnology Market Revenue (US$ Mn) and Forecasts,
By Application
14.6.4.3.1. Bio- Engineering
14.6.4.3.2. Drug Discovery
14.6.4.3.3. Genomics
14.6.4.3.4. Vaccines
14.6.4.3.5. Others
14.6.4.4. New Zealand Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By End Users
14.6.4.4.1. Hospitals
14.6.4.4.2. Research and Academic Institutes
14.6.4.4.3. Biotechnology and Pharmaceutical Institutes
14.6.4.4.4. Laboratories
14.6.4.4.5. Others
14.6.5. Australia
14.6.5.1. Australia Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Product
14.6.5.1.1. Oil
14.6.5.1.2. Enzymes
14.6.5.1.3. Functional ingredient and animal feed
14.6.5.1.4. Pharmaceuticals and Nutraceuticals
14.6.5.1.5. Foods and food additives
14.6.5.1.6. Cosmetics
14.6.5.1.7. Materials (e.g. clothes and construction materials
14.6.5.1.8. Energy
14.6.5.1.9. Others
14.6.5.2. Australia Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Usage
14.6.5.2.1. Human
14.6.5.2.2. Pets
14.6.5.2.3. Aquaculture
14.6.5.3. Australia Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.5.3.1. Bio- Engineering
14.6.5.3.2. Drug Discovery
14.6.5.3.3. Genomics
14.6.5.3.4. Vaccines
14.6.5.3.5. Others
14.6.5.4. Australia Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By End Users
14.6.5.4.1. Hospitals
14.6.5.4.2. Research and Academic Institutes
14.6.5.4.3. Biotechnology and Pharmaceutical Institutes
14.6.5.4.4. Laboratories
14.6.5.4.5. Others
14.6.6. South
Korea
14.6.6.1. South Korea Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Product
14.6.6.1.1. Oil
14.6.6.1.2. Enzymes
14.6.6.1.3. Functional ingredient and animal feed
14.6.6.1.4. Pharmaceuticals and Nutraceuticals
14.6.6.1.5. Foods and food additives
14.6.6.1.6. Cosmetics
14.6.6.1.7. Materials (e.g. clothes and construction materials
14.6.6.1.8. Energy
14.6.6.1.9. Others
14.6.6.2. South Korea Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Usage
14.6.6.2.1. Human
14.6.6.2.2. Pets
14.6.6.2.3. Aquaculture
14.6.6.3. South Korea Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.6.3.1. Bio- Engineering
14.6.6.3.2. Drug Discovery
14.6.6.3.3. Genomics
14.6.6.3.4. Vaccines
14.6.6.3.5. Others
14.6.6.4. South Korea Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By End Users
14.6.6.4.1. Hospitals
14.6.6.4.2. Research and Academic Institutes
14.6.6.4.3. Biotechnology and Pharmaceutical Institutes
14.6.6.4.4. Laboratories
14.6.6.4.5. Others
14.6.7. Southeast
Asia
14.6.7.1. Southeast Asia Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Product
14.6.7.1.1. Oil
14.6.7.1.2. Enzymes
14.6.7.1.3. Functional ingredient and animal feed
14.6.7.1.4. Pharmaceuticals and Nutraceuticals
14.6.7.1.5. Foods and food additives
14.6.7.1.6. Cosmetics
14.6.7.1.7. Materials (e.g. clothes and construction materials
14.6.7.1.8. Energy
14.6.7.1.9. Others
14.6.7.2. Southeast Asia Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Usage
14.6.7.2.1. Human
14.6.7.2.2. Pets
14.6.7.2.3. Aquaculture
14.6.7.3. Southeast Asia Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.7.3.1. Bio- Engineering
14.6.7.3.2. Drug Discovery
14.6.7.3.3. Genomics
14.6.7.3.4. Vaccines
14.6.7.3.5. Others
14.6.7.4. Southeast Asia Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By End Users
14.6.7.4.1. Hospitals
14.6.7.4.2. Research and Academic Institutes
14.6.7.4.3. Biotechnology and Pharmaceutical Institutes
14.6.7.4.4. Laboratories
14.6.7.4.5. Others
14.6.7.5. Southeast Asia Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Country
14.6.7.5.1. Indonesia
14.6.7.5.2. Thailand
14.6.7.5.3. Malaysia
14.6.7.5.4. Singapore
14.6.7.5.5. Rest of Southeast Asia
14.6.8. Rest of
Asia Pacific
14.6.8.1. Rest of Asia Pacific Blue Biotechnology Market Revenue (US$
Mn) and Forecasts, By Product
14.6.8.1.1. Oil
14.6.8.1.2. Enzymes
14.6.8.1.3. Functional ingredient and animal feed
14.6.8.1.4. Pharmaceuticals and Nutraceuticals
14.6.8.1.5. Foods and food additives
14.6.8.1.6. Cosmetics
14.6.8.1.7. Materials (e.g. clothes and construction materials
14.6.8.1.8. Energy
14.6.8.1.9. Others
14.6.8.2. Rest of Asia Pacific Blue Biotechnology Market Revenue (US$
Mn) and Forecasts, By Usage
14.6.8.2.1. Human
14.6.8.2.2. Pets
14.6.8.2.3. Aquaculture
14.6.8.3. Rest of Asia Pacific Blue Biotechnology Market Revenue (US$
Mn) and Forecasts, By Application
14.6.8.3.1. Bio- Engineering
14.6.8.3.2. Drug Discovery
14.6.8.3.3. Genomics
14.6.8.3.4. Vaccines
14.6.8.3.5. Others
14.6.8.4. Rest of Asia Pacific Blue Biotechnology Market Revenue (US$
Mn) and Forecasts, By End Users
14.6.8.4.1. Hospitals
14.6.8.4.2. Research and Academic Institutes
14.6.8.4.3. Biotechnology and Pharmaceutical Institutes
14.6.8.4.4. Laboratories
14.6.8.4.5. Others
14.7. Key
Segment for Channeling Investments
14.7.1. By
Country
14.7.2. By
Product
14.7.3. By
Usage
14.7.4. By
Application
14.7.5. By End
Users
15. Middle East and Africa Blue Biotechnology Market Analysis and
Forecasts, 2023 – 2031
15.1. Overview
15.1.1. Middle
East and Africa Blue Biotechnology Market Revenue (US$ Mn)
15.2. Middle
East and Africa Blue Biotechnology Market Revenue (US$ Mn) and Forecasts, By
Product
15.2.1. Oil
15.2.2. Enzymes
15.2.3. Functional
ingredient and animal feed
15.2.4. Pharmaceuticals
and Nutraceuticals
15.2.5. Foods
and food additives
15.2.6. Cosmetics
15.2.7. Materials
(e.g. clothes and construction materials
15.2.8. Energy
15.2.9. Others
15.3. Middle
East and Africa Blue Biotechnology Market Revenue (US$ Mn) and Forecasts, By
Usage
15.3.1. Human
15.3.2. Pets
15.3.3. Aquaculture
15.4. Middle
East and Africa Blue Biotechnology Market Revenue (US$ Mn) and Forecasts, By
Application
15.4.1. Bio-
Engineering
15.4.2. Drug Discovery
15.4.3. Genomics
15.4.4. Vaccines
15.4.5. Others
15.5. Middle
East and Africa Blue Biotechnology Market Revenue (US$ Mn) and Forecasts, By
End Users
15.5.1. Hospitals
15.5.2. Research
and Academic Institutes
15.5.3. Biotechnology
and Pharmaceutical Institutes
15.5.4. Laboratories
15.5.5. Others
15.6. Middle
East and Africa Blue Biotechnology Market Revenue (US$ Mn) and Forecasts, By
Country
15.6.1. Saudi
Arabia
15.6.1.1. Saudi Arabia Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Product
15.6.1.1.1. Oil
15.6.1.1.2. Enzymes
15.6.1.1.3. Functional ingredient and animal feed
15.6.1.1.4. Pharmaceuticals and Nutraceuticals
15.6.1.1.5. Foods and food additives
15.6.1.1.6. Cosmetics
15.6.1.1.7. Materials (e.g. clothes and construction materials
15.6.1.1.8. Energy
15.6.1.1.9. Others
15.6.1.2. Saudi Arabia Blue Biotechnology Market Revenue (US$ Mn) and Forecasts,
By Usage
15.6.1.2.1. Human
15.6.1.2.2. Pets
15.6.1.2.3. Aquaculture
15.6.1.3. Saudi Arabia Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Application
15.6.1.3.1. Bio- Engineering
15.6.1.3.2. Drug Discovery
15.6.1.3.3. Genomics
15.6.1.3.4. Vaccines
15.6.1.3.5. Others
15.6.1.4. Saudi Arabia Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By End Users
15.6.1.4.1. Hospitals
15.6.1.4.2. Research and Academic Institutes
15.6.1.4.3. Biotechnology and Pharmaceutical Institutes
15.6.1.4.4. Laboratories
15.6.1.4.5. Others
15.6.2. UAE
15.6.2.1. UAE Blue Biotechnology Market Revenue (US$ Mn) and Forecasts,
By Product
15.6.2.1.1. Oil
15.6.2.1.2. Enzymes
15.6.2.1.3. Functional ingredient and animal feed
15.6.2.1.4. Pharmaceuticals and Nutraceuticals
15.6.2.1.5. Foods and food additives
15.6.2.1.6. Cosmetics
15.6.2.1.7. Materials (e.g. clothes and construction materials
15.6.2.1.8. Energy
15.6.2.1.9. Others
15.6.2.2. UAE Blue Biotechnology Market Revenue (US$ Mn) and Forecasts,
By Usage
15.6.2.2.1. Human
15.6.2.2.2. Pets
15.6.2.2.3. Aquaculture
15.6.2.3. UAE Blue Biotechnology Market Revenue (US$ Mn) and Forecasts,
By Application
15.6.2.3.1. Bio- Engineering
15.6.2.3.2. Drug Discovery
15.6.2.3.3. Genomics
15.6.2.3.4. Vaccines
15.6.2.3.5. Others
15.6.2.4. UAE Blue Biotechnology Market Revenue (US$ Mn) and Forecasts,
By End Users
15.6.2.4.1. Hospitals
15.6.2.4.2. Research and Academic Institutes
15.6.2.4.3. Biotechnology and Pharmaceutical Institutes
15.6.2.4.4. Laboratories
15.6.2.4.5. Others
15.6.3. Egypt
15.6.3.1. Egypt Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Product
15.6.3.1.1. Oil
15.6.3.1.2. Enzymes
15.6.3.1.3. Functional ingredient and animal feed
15.6.3.1.4. Pharmaceuticals and Nutraceuticals
15.6.3.1.5. Foods and food additives
15.6.3.1.6. Cosmetics
15.6.3.1.7. Materials (e.g. clothes and construction materials
15.6.3.1.8. Energy
15.6.3.1.9. Others
15.6.3.2. Egypt Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Usage
15.6.3.2.1. Human
15.6.3.2.2. Pets
15.6.3.2.3. Aquaculture
15.6.3.3. Egypt Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Application
15.6.3.3.1. Bio- Engineering
15.6.3.3.2. Drug Discovery
15.6.3.3.3. Genomics
15.6.3.3.4. Vaccines
15.6.3.3.5. Others
15.6.3.4. Egypt Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By End Users
15.6.3.4.1. Hospitals
15.6.3.4.2. Research and Academic Institutes
15.6.3.4.3. Biotechnology and Pharmaceutical Institutes
15.6.3.4.4. Laboratories
15.6.3.4.5. Others
15.6.4. Kuwait
15.6.4.1. Kuwait Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Product
15.6.4.1.1. Oil
15.6.4.1.2. Enzymes
15.6.4.1.3. Functional ingredient and animal feed
15.6.4.1.4. Pharmaceuticals and Nutraceuticals
15.6.4.1.5. Foods and food additives
15.6.4.1.6. Cosmetics
15.6.4.1.7. Materials (e.g. clothes and construction materials
15.6.4.1.8. Energy
15.6.4.1.9. Others
15.6.4.2. Kuwait Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Usage
15.6.4.2.1. Human
15.6.4.2.2. Pets
15.6.4.2.3. Aquaculture
15.6.4.3. Kuwait Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Application
15.6.4.3.1. Bio- Engineering
15.6.4.3.2. Drug Discovery
15.6.4.3.3. Genomics
15.6.4.3.4. Vaccines
15.6.4.3.5. Others
15.6.4.4. Kuwait Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By End Users
15.6.4.4.1. Hospitals
15.6.4.4.2. Research and Academic Institutes
15.6.4.4.3. Biotechnology and Pharmaceutical Institutes
15.6.4.4.4. Laboratories
15.6.4.4.5. Others
15.6.5. South
Africa
15.6.5.1. South Africa Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Product
15.6.5.1.1. Oil
15.6.5.1.2. Enzymes
15.6.5.1.3. Functional ingredient and animal feed
15.6.5.1.4. Pharmaceuticals and Nutraceuticals
15.6.5.1.5. Foods and food additives
15.6.5.1.6. Cosmetics
15.6.5.1.7. Materials (e.g. clothes and construction materials
15.6.5.1.8. Energy
15.6.5.1.9. Others
15.6.5.2. South Africa Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Usage
15.6.5.2.1. Human
15.6.5.2.2. Pets
15.6.5.2.3. Aquaculture
15.6.5.3. South Africa Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Application
15.6.5.3.1. Bio- Engineering
15.6.5.3.2. Drug Discovery
15.6.5.3.3. Genomics
15.6.5.3.4. Vaccines
15.6.5.3.5. Others
15.6.5.4. South Africa Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By End Users
15.6.5.4.1. Hospitals
15.6.5.4.2. Research and Academic Institutes
15.6.5.4.3. Biotechnology and Pharmaceutical Institutes
15.6.5.4.4. Laboratories
15.6.5.4.5. Others
15.6.6. Rest of
Middle East & Africa
15.6.6.1. Rest of Middle East & Africa Blue Biotechnology Market
Revenue (US$ Mn) and Forecasts, By Product
15.6.6.1.1. Oil
15.6.6.1.2. Enzymes
15.6.6.1.3. Functional ingredient and animal feed
15.6.6.1.4. Pharmaceuticals and Nutraceuticals
15.6.6.1.5. Foods and food additives
15.6.6.1.6. Cosmetics
15.6.6.1.7. Materials (e.g. clothes and construction materials
15.6.6.1.8. Energy
15.6.6.1.9. Others
15.6.6.2. Rest of Middle East & Africa Blue Biotechnology Market
Revenue (US$ Mn) and Forecasts, By Usage
15.6.6.2.1. Human
15.6.6.2.2. Pets
15.6.6.2.3. Aquaculture
15.6.6.3. Rest of Middle East & Africa Blue Biotechnology Market
Revenue (US$ Mn) and Forecasts, By Application
15.6.6.3.1. Bio- Engineering
15.6.6.3.2. Drug Discovery
15.6.6.3.3. Genomics
15.6.6.3.4. Vaccines
15.6.6.3.5. Others
15.6.6.4. Rest of Middle East & Africa Blue Biotechnology Market
Revenue (US$ Mn) and Forecasts, By End Users
15.6.6.4.1. Hospitals
15.6.6.4.2. Research and Academic Institutes
15.6.6.4.3. Biotechnology and Pharmaceutical Institutes
15.6.6.4.4. Laboratories
15.6.6.4.5. Others
15.7. Key
Segment for Channeling Investments
15.7.1. By
Country
15.7.2. By
Product
15.7.3. By
Usage
15.7.4. By
Application
15.7.5. By End
Users
16. Latin America Blue Biotechnology Market Analysis and
Forecasts, 2023 – 2031
16.1. Overview
16.1.1. Latin
America Blue Biotechnology Market Revenue (US$ Mn)
16.2. Latin
America Blue Biotechnology Market Revenue (US$ Mn) and Forecasts, By Product
16.2.1. Oil
16.2.2. Enzymes
16.2.3. Functional
ingredient and animal feed
16.2.4. Pharmaceuticals
and Nutraceuticals
16.2.5. Foods
and food additives
16.2.6. Cosmetics
16.2.7. Materials
(e.g. clothes and construction materials
16.2.8. Energy
16.2.9. Others
16.3. Latin
America Blue Biotechnology Market Revenue (US$ Mn) and Forecasts, By Usage
16.3.1. Human
16.3.2. Pets
16.3.3. Aquaculture
16.4. Latin
America Blue Biotechnology Market Revenue (US$ Mn) and Forecasts, By
Application
16.4.1. Bio-
Engineering
16.4.2. Drug Discovery
16.4.3. Genomics
16.4.4. Vaccines
16.4.5. Others
16.5. Latin
America Blue Biotechnology Market Revenue (US$ Mn) and Forecasts, By End Users
16.5.1. Hospitals
16.5.2. Research
and Academic Institutes
16.5.3. Biotechnology
and Pharmaceutical Institutes
16.5.4. Laboratories
16.5.5. Others
16.6. Latin
America Blue Biotechnology Market Revenue (US$ Mn) and Forecasts, By Country
16.6.1. Brazil
16.6.1.1. Brazil Blue Biotechnology Market Revenue (US$ Mn) and Forecasts,
By Product
16.6.1.1.1. Oil
16.6.1.1.2. Enzymes
16.6.1.1.3. Functional ingredient and animal feed
16.6.1.1.4. Pharmaceuticals and Nutraceuticals
16.6.1.1.5. Foods and food additives
16.6.1.1.6. Cosmetics
16.6.1.1.7. Materials (e.g. clothes and construction materials
16.6.1.1.8. Energy
16.6.1.1.9. Others
16.6.1.2. Brazil Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Usage
16.6.1.2.1. Human
16.6.1.2.2. Pets
16.6.1.2.3. Aquaculture
16.6.1.3. Brazil Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Application
16.6.1.3.1. Bio- Engineering
16.6.1.3.2. Drug Discovery
16.6.1.3.3. Genomics
16.6.1.3.4. Vaccines
16.6.1.3.5. Others
16.6.1.4. Brazil Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By End Users
16.6.1.4.1. Hospitals
16.6.1.4.2. Research and Academic Institutes
16.6.1.4.3. Biotechnology and Pharmaceutical Institutes
16.6.1.4.4. Laboratories
16.6.1.4.5. Others
16.6.2. Argentina
16.6.2.1. Argentina Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Product
16.6.2.1.1. Oil
16.6.2.1.2. Enzymes
16.6.2.1.3. Functional ingredient and animal feed
16.6.2.1.4. Pharmaceuticals and Nutraceuticals
16.6.2.1.5. Foods and food additives
16.6.2.1.6. Cosmetics
16.6.2.1.7. Materials (e.g. clothes and construction materials
16.6.2.1.8. Energy
16.6.2.1.9. Others
16.6.2.2. Argentina Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Usage
16.6.2.2.1. Human
16.6.2.2.2. Pets
16.6.2.2.3. Aquaculture
16.6.2.3. Argentina Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By Application
16.6.2.3.1. Bio- Engineering
16.6.2.3.2. Drug Discovery
16.6.2.3.3. Genomics
16.6.2.3.4. Vaccines
16.6.2.3.5. Others
16.6.2.4. Argentina Blue Biotechnology Market Revenue (US$ Mn) and
Forecasts, By End Users
16.6.2.4.1. Hospitals
16.6.2.4.2. Research and Academic Institutes
16.6.2.4.3. Biotechnology and Pharmaceutical Institutes
16.6.2.4.4. Laboratories
16.6.2.4.5. Others
16.6.3. Rest of
Latin America
16.6.3.1. Rest of Latin America Blue Biotechnology Market Revenue (US$
Mn) and Forecasts, By Product
16.6.3.1.1. Oil
16.6.3.1.2. Enzymes
16.6.3.1.3. Functional ingredient and animal feed
16.6.3.1.4. Pharmaceuticals and Nutraceuticals
16.6.3.1.5. Foods and food additives
16.6.3.1.6. Cosmetics
16.6.3.1.7. Materials (e.g. clothes and construction materials
16.6.3.1.8. Energy
16.6.3.1.9. Others
16.6.3.2. Rest of Latin America Blue Biotechnology Market Revenue (US$
Mn) and Forecasts, By Usage
16.6.3.2.1. Human
16.6.3.2.2. Pets
16.6.3.2.3. Aquaculture
16.6.3.3. Rest of Latin America Blue Biotechnology Market Revenue (US$
Mn) and Forecasts, By Application
16.6.3.3.1. Bio- Engineering
16.6.3.3.2. Drug Discovery
16.6.3.3.3. Genomics
16.6.3.3.4. Vaccines
16.6.3.3.5. Others
16.6.3.4. Rest of Latin America Blue Biotechnology Market Revenue (US$
Mn) and Forecasts, By End Users
16.6.3.4.1. Hospitals
16.6.3.4.2. Research and Academic Institutes
16.6.3.4.3. Biotechnology and Pharmaceutical Institutes
16.6.3.4.4. Laboratories
16.6.3.4.5. Others
16.7. Key
Segment for Channeling Investments
16.7.1. By
Country
16.7.2. By
Product
16.7.3. By
Usage
16.7.4. By
Application
16.7.5. By End
Users
17. Competitive Benchmarking
17.1. Brand
Benchmarking
17.2. Market
Share Analysis, 2022
17.3. Global Presence
and Growth Strategies
17.3.1. Mergers
and Acquisitions
17.3.2. Product
Launches
17.3.3. Investments
Trends
17.3.4. R&D
Initiatives
18. Player Profiles
18.1. AKER
BIOMARINE
18.1.1. Company
Details
18.1.2. Company
Overview
18.1.3. Product
Offerings
18.1.4. Key
Developments
18.1.5. Financial
Analysis
18.1.6. SWOT
Analysis
18.1.7. Business
Strategies
18.2. Givaudan
18.2.1. Company
Details
18.2.2. Company
Overview
18.2.3. Product
Offerings
18.2.4. Key
Developments
18.2.5. Financial
Analysis
18.2.6. SWOT
Analysis
18.2.7. Business
Strategies
18.3. GlycoMar
18.3.1. Company
Details
18.3.2. Company
Overview
18.3.3. Product
Offerings
18.3.4. Key
Developments
18.3.5. Financial
Analysis
18.3.6. SWOT
Analysis
18.3.7. Business
Strategies
18.4. INTERDERMA
18.4.1. Company
Details
18.4.2. Company
Overview
18.4.3. Product
Offerings
18.4.4. Key
Developments
18.4.5. Financial
Analysis
18.4.6. SWOT
Analysis
18.4.7. Business
Strategies
18.5. LAGOSTA
18.5.1. Company
Details
18.5.2. Company
Overview
18.5.3. Product
Offerings
18.5.4. Key
Developments
18.5.5. Financial
Analysis
18.5.6. SWOT Analysis
18.5.7. Business
Strategies
18.6. Marinova
18.6.1. Company
Details
18.6.2. Company
Overview
18.6.3. Product
Offerings
18.6.4. Key
Developments
18.6.5. Financial
Analysis
18.6.6. SWOT
Analysis
18.6.7. Business
Strategies
18.7. New England Biolabs (UK) Ltd.
18.7.1. Company
Details
18.7.2. Company
Overview
18.7.3. Product
Offerings
18.7.4. Key Developments
18.7.5. Financial
Analysis
18.7.6. SWOT
Analysis
18.7.7. Business
Strategies
18.8. PML Applcations
18.8.1. Company
Details
18.8.2. Company
Overview
18.8.3. Product
Offerings
18.8.4. Key
Developments
18.8.5. Financial
Analysis
18.8.6. SWOT
Analysis
18.8.7. Business
Strategies
18.9. Samudra Biopharma Pvt. Ltd
18.9.1. Company
Details
18.9.2. Company
Overview
18.9.3. Product
Offerings
18.9.4. Key
Developments
18.9.5. Financial
Analysis
18.9.6. SWOT
Analysis
18.9.7. Business
Strategies
18.10. Sanosil Biotech
18.10.1. Company
Details
18.10.2. Company
Overview
18.10.3. Product
Offerings
18.10.4. Key
Developments
18.10.5. Financial
Analysis
18.10.6. SWOT
Analysis
18.10.7. Business
Strategies
18.11. Other
Market Participants
19. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User
and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.